The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 4, 1998, Pages 385-388

  Thakker, Rajesh V ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BUMETANIDE; CHLORIDE CHANNEL; SODIUM CHLORIDE; THIAZIDE DIURETIC AGENT;

BARTTER SYNDROME; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CALCIFICATION; KIDNEY DISEASE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW; SYNDROME DELINEATION; VOLTAGE CLAMP;

ANIMALS; CHLORIDE CHANNELS; HUMANS; KIDNEY; KIDNEY CALCULI; NEPHROCALCINOSIS;

EID: 0031829461     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199807000-00006     Document Type: Review

References (42)

1. Brown EM. Mutations in the calcium-sensing receptor and their clinical • implications. Horm Res 1997; 48:199-208. This is a concise review of the role of the calcium-sensing receptor and its associated disorders of electrolyte homeostasis.
2. ++-sensing receptor in • the divalent mineral ion homeostasis. J Exp Biol 1997; 200:295-302. An excellent review of the calcium-sensing receptor and its role in renal tubular mineral homeostasis.
3. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, •• Stone R, et al. Mutations in the chloride channel gene CLCNKB, cause Bartter's syndrome type III. Nature Genet 1997; 17:171-178. Excellent study characterising the CLCNKa and CLCNKb genes and identifying CLCNKb mutations in Bartter's syndrome.
4. Thakker RV. Chloride channels cough up. Nature Genet 1997; • 17:125-127. This is a review of the families of CLCs and their disease associations.
5. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Litton RP, Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria. is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nature Genet 1996; 13:183-188.
6. Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nature Genet 1996; 12:24-30
7. Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH. DiPietro A, Trachtman H, Sanjad SA, Lifton RP. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K · channel, ROMK. Nature Genet 1996; 14:152-156.
8. International Collaborative Study Group for Bartter-like syndromes. • Human Mol Genet 1997; 6:17-26. This is a comprehensive study of ROMK mutations in a form of Bartter's syndrome.
9. Lloyd SE Pearce SHS, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, et al. A common molecular basis for three inherited kidney stone diseases. Nature 1996; 379:445-449.
10. Lloyd SE, Pearce SHS, Gunter W, Kawaguchi H, Igarashi T, Jentsch TJ, •• Thakker RV Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5). J Clin Invest 1997; 99:967-974. A detailed study of CLCN5mutations in the Japanese variant of Dent's disease. Demonstration of functional alterations in Cl currently resulting from CLCN5 mutations, using heterologous expression in Xenopus oocytes Illustrates value of single-stranded conformational polymorphisms analysis in the detection of CLCN5 mutations.
11. Lloyd SE, Gunter W, Pearce SHS, Thomson A, Bianchi ML, Bosio M, et al. •• Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders. Human Mol Genet 1997; 6:1233-1239. This is a comprehensive study of CLCN5 mutations in Dent's disease. Demonstration of de novo mutations and functional studies.
12. Akuta N, Lloyd SE, Igarashi T, Shiraga H, Matsuyama T, Yokoro S, et al. • Mutational analysis of the renal chloride channel (CLCN5) in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis. Kidney Int 1997; 52:911-916. This paper presents characterisation of substantial number of CLCN5 mutations in Japanese variant of Dent's disease together with clinical details.
13. Wrong OM, Norden AGW, Feest TG, Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. Q J Med 1994; 87:473-493.
14. Pook MA, Wrong OM, Wooding C, Norden AGW, Feest TG, Thakker RV, Dent's disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a microdeletion involving DXS255 and maps to Xp11.22. Hum Mol Genet 1993; 2:2129-2134.
15. Frymoyer PA, Scheinman SJ, Dunham PB, Jones DB, Hueber P, Schroeder ET, X-linked recessive nephrolithiasis with renal failure. N Eng J Med 1991; 325:681-686.
16. Scheinman SJ, Pook MA, Wooding C, Pang JT, Frymoyer PA, Thakker RV. Mapoing the gene causing X-linked recessive nephrolithiasis to Xp11.22 by linkage studies. J Clin Invest 1993; 91:2351-2357.
17. Bolino A, Devoto M, Enia G, Zoccali C, Weissenbach, Romeo G. Genetic mapping in the Xp11.2 region of a new form of X-linked hypophosphatemic rickets. Eur J Hum Genet 1993; 1:269-279
18. Igarashi T, Hayakawa H, Shiraga H, Kawato H, Yan K, Kawaguchi H, et al. Hypercalciuria nephracalcinosis in patients with idiopathic low molecular weight proteinuria in Japan: is this identical to Dent's disease in the United Kingdom? Nephron 1995; 69:242-247.
19. Oudet C, Martin-Coignard D, Pannetier S, Praud E, Champion G, Hanauer A. A second family with XLRH displays the mutation S244L in the CLCN5 gene. Human Genet 1997; 99:781-784.
20. Nakazato H, Hattori S, Furuse A, Kawano T, Karashima S, Tsuruta M, et al. Mutations in the CLCN5 gene in Japanese patients with familial idiopathic low-molecular-weight proteinuria. Kidney Int 1997; 52:895-900.
21. Fisher SE, Black GCM, Lloyd SE, Wrong OM, Thakker RV, Craig IW, Isolation and partial characterisation of a human chloride channel gene which is expressed in kidney and is a candidate for Dent's disease (an hereditary nephrolithiasis). Hum Mol Genet 1994; 3:2053-2059.
22. Fisher SE, van Bakel I, Lloyd SE, Pearce SHS, Thakker RV, Craig IW. Cloning and characterisation of CIC-5, the human kidney chloride channel gene implicated in Dent's disease (an X-linked hereditary nephrolithiasis). Genomics 1995; 29:598-606
23. Kelleher CL, Buckalew OM, Frederickson ED, Rhodes DJ, Conner DA, Seidman JG, Seidman CE. CLCN5 mutation Ser244Leu is associated with X-linked renal failure without X-linked recessive hypophosphataemic rickets. Kidney Int 1998; 53:31-37.
24. Wrong OM, Unwin R, Cohen E, Tanner M, Thakker RV. Unravelling of the molecular mechanisms of kidney stones. Lancet 1996; 348:1561-1565.
25. Scheinman SJ. X-linked hypercalciuric nephrolithiasis: clinical syndromes • and chloride channel mutations. Kidney Int 1998; 53:3-17. This is an excellent review of clinical features of the different hypercalciuric nephrolithiasis disorders together with CLC-5 mutations.
26. Hebert SC. Crystal clear chloride channels. Nature 1996; 379:398-399
27. Christensen E, Nielsen S. Structural and functional features of protein handling in the kidney proximal tubule. Semin Nephrol 1991; 11:414-439.
28. Grenningloh G, Rienitz A, Schmitt B, Methfessel C, Zensen M, Beyreuther K, et al. The strychnine-binding sub-unit of the glycine receptor shows homology with nicotinic acetylcholine receptors. Nature 1987; 328:215-220.
29. A receptor shows a ligand-gated receptor super-family. Nature 1987; 328:221-227.
30. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245:1066-1073.
31. Jentsch TJ, Steinmeyer K, Schwarz G. Primary structure of Torpedo marmorata chloride channel isolated by expression cloning in Xenopus oocytes. Nature 1990; 348:510-514.
32. Jentsch TJ, Gunther W, Pusch M, Schwappach B. Properties of voltage-gated chloride channels of the CIC gene family. J Physiol 1990; 482:19S-25S.
33. Fahlke C, Yu HT, Beck CL, Rhodes TH, George AL Jr. Pore-forming •• segments in voltage-gated chloride channels. Nature 1997; 390:529-532. This elegant study defines a potential functional pore for chloride transport.
34. Schmidt-Rose T, Jentsch TJ. Transmembrane topology of a CLC chloride •• channel. Proc Natl Acad Sci USA 1997; 94:7633-7638. These excellent comprehensive studies clarify the topology of these complex CLCs.
35. Brandt S, Jentsch TJ. CL-6 and CLC-7 are two novel broadly expressed members of the CLC chloride channel family. FEBS Lett 1995; 377:15-20.
36. Ludewig U, Pusch M, Jentsch TJ. Two physically distinct pores in the dimeric CLC-0 chloride channel. Nature 1996; 383:340-343.
37. Middleton RE, Pheasant DJ, Miller C. Homodimeric architecture of a CLC-type chloride ion channel. Nature 1996; 383:337-340.
38. Koch MC, Steinmeyer K, Lorenz C, Ricker K, Wolf F, Otto M, et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992; 257:797-800.
39. Steinmeyer K, Lorenz C, Pusch M, Koch MC, Jentsch TJ. Multimeric structure of CLC-1 chloride channel revealed by mutations in dominant myotonia congenita (Thomsen). EMBO J 1994; 13:737-743.
40. Meyer-Kleine C, Steinmeyer K, Ricker K, Jentsch TJ, Koch-MC. Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia. Am J Hum Genet 1995; 57:1325-1334.
41. Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, et al. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 1992; 359:233-235.
42. Obermuller N, Gret Z, Kriz W, Reilly RF, Witzgall R. The swelling activated chloride channel CLC-2, the chloride channel CLC-3, and CLC-5, a chloride channel mutation in kidney stone disease, are expressed in distinct sub-populations of renal epithelial cells. J Clin Invest 1998; 101:635-642.